Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

ASKO THERAPEUTICS, INC. — Funding, Investors & Profile — Capbase

← All companies

Compare History

ASKO THERAPEUTICS, INC.

Private

Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: HXZAWBGUS6X6

Founded: —Source: [GOV]
Headquarters: Ann Arbor, MichiganSource: [GOV]
Headcount: 3Source: [GOV]
Stage: Seed
Sector: Technology

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

ASKO THERAPEUTICS, INC. has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $700,054 in 2025. These are non-dilutive federal research grants, not equity financing. The company is based in Ann Arbor, Michigan.

Funding rounds

2 rounds

SBIR Phase I award (HHS)GrantJul 2025Source: [GOV]
$350K
—post-money
SBIR Phase I award (HHS)

Investors

No investors recorded yet for ASKO THERAPEUTICS, INC..

Add an investor

People

Leadership

VISHALAKSHI KRISHNANPrincipal investigatorSince 2025Source: [GOV]

Acquisitions

ASKO THERAPEUTICS, INC. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for ASKO THERAPEUTICS, INC..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Grant

Aug 2025Source: [GOV]

$350K

—post-money